OneTouch Ping Recalled by Animas


By: dhtest

David Kliff of Diabetic Investor was the first to report last week that Animas, the Johnson and Johnson unit that makes the  OneTouch Ping blood glucose monitor, is recalling the Ping. The brand-new Ping received FDA clearance this past summer on July 1. According to reports, there is a small problem with the Ping that has nothing to do with the Animas 2020 insulin pump it works in concert with. The bolus calculator on the Ping does not work properly when it isn’t synched with the pump. When the two are synched, it works fine. Animas says the problem has been corrected and they are sending new units to customers to replace the defective ones.

Kliff said in his newsletter that he doesn’t see it as “an overly serious issue.” he writes, “Based on everything Diabetic Investor has learned, the issue is software-related and Animas is being proactive here [in] not letting a minor issue turn into a major one.”

For more information, call Animas at (877) 937-7867.




Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.